COA in PROgress

Boehringer Ingelheim GMBH
  • ٥٫٠ (١)
  • المجتمع والثقافة
  • يتم التحديث أسبوعيًا

Discover the future of Clinical Outcome Assessments from leading industry voices with our brand-new podcast series, COA in PROgress.

الحلقات

  1. ٢٦‏/٠٥‏/٢٠٢٤

    COA landscape: What’s next?

    What does the future of COA's look like? This week's guests John Fox & Olivier Wong deep-dive into the digital and tech landscape, alongside evidence quality barriers, alternate viewpoints, and the importance of a patient-centric process to payers and regulators.

    ٣٢ من الدقائق

  2. ١٩‏/٠٥‏/٢٠٢٤

    PRO measures in daily clinical practice

    From complexity to variety, how do PRO measures affect the day-to-day of clinical practice? Experts Ethan Basch and Norah Crossnohere are here to explain – all while evaluating the landscape of current practice, how it helps patient and providers, and potential future process adjustments.

    ٣٧ من الدقائق

  3. ١٢‏/٠٥‏/٢٠٢٤

    COA measures in a digital landscape

    In this week's episode, Matt is joined by Mel Calvert and Hilary Jones to discuss how to choose the right digital COA measures in clinical research. In particular, what do we want to measure in the trial, why do we want to measure it, and what needs consideration to minimize the risk of missing data?

    ٣١ من الدقائق

  4. ٠٥‏/٠٥‏/٢٠٢٤

    How do we specify COA endpoints?

    How do we specify clinical outcome assessment endpoints? In this COA in PROgress podcast episode John Powers and Cheryl Coon offer insight into how to frame an endpoint that contains clinical outcome assessment data.

    ٢٩ من الدقائق

  5. ٢٨‏/٠٤‏/٢٠٢٤

    Are your measures measuring up?

    Patient-reported outcome measures – are there too many or too few? Professors Michael Brundage and David Cella debate this question and deep-dive into a few patient prioritization measures on this week's all-new episode, including the criteria for validity, reliability, and scoring interpretability.

    ٣٨ من الدقائق

  6. ٢١‏/٠٤‏/٢٠٢٤

    The development of a patient-centric strategy in clinical research

    How do you create a good end-to-end patient centered drug development strategy?  Join Sonya Eremenco and John Powers as they discuss why it's important to put patients at the heart of COA approaches – from concept to endpoint positioning, and the most crucial steps in between.

    ٣١ من الدقائق

  7. ١٠‏/٠٤‏/٢٠٢٤

    The use of COA in patient-centered drug development: part 2

    This week, we're putting the PRO in PROgress by discussing Patient Reported Outcomes with guests Paul Miller and Olivier Wong. In particular, how they're shaping the world of health technology assessment.

    ٣٦ من الدقائق
  8. The use of COA in patient-centered drug development: part 1

    ٠٣‏/٠٤‏/٢٠٢٤

    The use of COA in patient-centered drug development: part 1

    From introduction to interpretation, join Dan O’Connor and Chad Gwaltney as they explore how best to meet the expectations of regulatory authorities. Including: demystifying COA guidance documents and discussing how they became an integral part of the regulatory landscape.

    ٣٤ من الدقائق
  • ٨ حلقة

حول

Discover the future of Clinical Outcome Assessments from leading industry voices with our brand-new podcast series, COA in PROgress.

المعلومات

  • صناع العمل
    Boehringer Ingelheim GMBH
  • سنوات النشاط
    ٢٠٢٤
  • الحلقات
    ٨
  • التقييم
    ملائم
  • موقع البرنامج على الويب
    COA in PROgress